コンテンツへスキップ
Merck

Stearic acid, clotting, and thrombosis.

The American journal of clinical nutrition (1994-12-01)
J C Hoak
要旨

Stearic acid causes hypercoagulability of the blood by activation of factor XII and by aggregation of blood platelets. Injection of unbound stearic acid (sodium salt) into the systemic circulation of dogs was followed by massive generalized thrombosis and sudden death. Similar infusions into birds, which are deficient in factor XII, did not cause hypercoagulability or thrombosis. The effects of the long-chain saturated fatty acids could be prevented by using albumin to bind the stearic acid at a molar ratio of free fatty acid (FFA) to albumin of < 2. The major issue is whether eating foods rich in stearic acid can cause a thrombogenic effect. We have no experimental evidence to support this concept. If a thrombogenic effect of long-chain saturated fatty acids exists in humans, it is most likely to occur as an aberration of fatty acid transport in which the FFA-albumin molar ratio exceeds 2 either as a result of very high plasma FFA concentrations from lipid mobilization or a low concentration of albumin in the blood as found in disease states such as the nephrotic syndrome.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ステアリン酸, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
ステアリン酸, reagent grade, 95%
Sigma-Aldrich
ステアリン酸, ≥95%, FCC, FG
USP
ステアリン酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ステアリン酸, SAJ first grade, ≥90.0%, powder
Supelco
ステアリン酸, analytical standard
Supelco
ステアリン酸, Pharmaceutical Secondary Standard; Certified Reference Material
ステアリン酸, European Pharmacopoeia (EP) Reference Standard
Supelco
ステアリン酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland